0001213900-20-031869.txt : 20201016 0001213900-20-031869.hdr.sgml : 20201016 20201016203727 ACCESSION NUMBER: 0001213900-20-031869 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201013 FILED AS OF DATE: 20201016 DATE AS OF CHANGE: 20201016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brady Brian Michael CENTRAL INDEX KEY: 0001817386 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39336 FILM NUMBER: 201245028 MAIL ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADiTx Therapeutics, Inc. CENTRAL INDEX KEY: 0001726711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823204328 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 BUSINESS PHONE: 909-488-0844 MAIL ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 4/A 1 ownership.xml X0306 4/A 2020-10-13 2020-10-15 0 0001726711 ADiTx Therapeutics, Inc. ADTX 0001817386 Brady Brian Michael C/O ADITX THERAPEUTICS, INC. 11161 ANDERSON STREET, SUITE 105-10014 LOMA LINDA CA 92354 1 0 0 0 Stock Option (Right to Buy) 1.94 2020-10-13 4 A 0 10000 0 A 2030-10-13 Common Stock 10000 10000 D 25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020. This Amendment is being filed to correct a clerical error. Column 4 in Table II has been changed to reflect the transaction as an acquisition rather than a disposition. /s/ Brian M. Brady 2020-10-16